Sudden cardiac death won't go away: What are we to do?

Heart Rhythm

Volumn 8, Issue 8, 2011, Pages 1183-1184

  Buxton, Alfred E ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DEFIBRILLATOR; ELECTROCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE FUNCTION; HUMAN; HYPERTENSION; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SUDDEN DEATH;

EID: 79960782468     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2011.04.016     Document Type: Editorial

References (21)

1. A. Haider, M. Larson, E. Benjamin, and D. Levy Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death J Am Coll Cardiol 32 1998 1454 1459 (Pubitemid 28522409)
2. M. East, J. Jollis, C. Nelson, D. Marks, and E. Peterson The influence of left ventricular hypertrophy on survival in patients with coronary artery disease: do race and gender matter? J Am Coll Cardiol 41 2003 949 954 (Pubitemid 36315535)
3. W. Kannel, J. Doyle, P. McNamara, P. Quickenton, and T. Gordon Precursors of sudden coronary death: Factors related to the incidence of sudden death Circulation 51 1975 606 613
4. C. Westerhout, M. Lauer, and S. James Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: An important risk marker of mortality in women Eur Heart J 28 2007 2064 2069 (Pubitemid 350019395)
5. D. Siscovick, T. Raghunathan, and P. Rautaharju Clinically silent electrocardiographic abnormalities and risk of primary cardiac arrest among hypertensive patients Circulation 94 1996 1329 1333 (Pubitemid 26307261)
6. J. Mathew, P. Sleight, and E. Lonn Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril Circulation 104 2001 1615 1621 (Pubitemid 32947523)
7. P. Okin, R. Devereux, and S. Jern Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events JAMA 292 2004 2343 2349 (Pubitemid 39491918)
8. K. Wachtell, P. Okin, and M. Olsen Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE study Circulation 116 2007 700 705 (Pubitemid 47260463)
9. K. Reinier, C. Dervan, and T. Singh Increased left ventricular mass and decreased left ventricular systolic function have independent pathways to ventricular arrhythmogenesis in coronary artery disease Heart Rhythm 8 2011 1177 1182
10. A. Buxton, K. Lee, and G. Hafley Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease Lessons from the MUSTT study J Am Coll Cardiol 50 2007 1150 1157 (Pubitemid 47375017)
11. I. Goldenberg, A. Vyas, and W. Hall Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction J Am Coll Cardiol 51 2008 288 296
12. J. McLenachan, E. Henderson, K. Morris, and H. Dargie Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy N Engl J Med 317 1987 787 792 (Pubitemid 17133358)
13. M. Messerli, H. Ventura, D. Elizardi, F. Dunn, and E. Frohlich Hypertension and sudden death Increased ventricular ectopic activity in left ventricular hypertrophy Amer J Med 77 1984 18 22 (Pubitemid 14084901)
14. D. Levy, K. Anderson, and D. Savage Risk of ventricular arrhythmias in left ventricular hypertrophy: the Framingham heart study Am J Cardiol 60 1987 560 565 (Pubitemid 17138871)
15. P. Zimetbaum, A. Buxton, and W. Batsford Electrocardiographic predictors of arrhythmic death and total mortality in the multicenter unsustained tachycardia trial Circulation 110 2004 766 769 (Pubitemid 39096001)
16. M. Turakhia, N. Schiller, and M. Whooley Prognostic significance of increased left ventricular mass index to mortality and sudden death in patients with stable coronary heart disease (from the heart and soul study) Am J Cardiol 102 2008 1131 1135
17. H. McIntyre, and C. Fry Abnormal action potential conduction in isolated human hypertrophied left ventricular myocardium J Cardiovasc Electrophysiol 8 1997 887 894 (Pubitemid 27329095)
18. N. Peters, C. Green, P. Poole-Wilson, and N. Severs Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts Circulation 88 1993 864 875 (Pubitemid 23264001)
19. Y. Kon-No, J. Watanabe, and Y. Koseki Microvolt t wave alternans in human cardiac hypertrophy: Electrical instability and abnormal myocardial arrangement J Cardiovasc Electrophysiol 12 2001 759 763 (Pubitemid 32607253)
20. T. Seccia, A. Belloni, and R. Kreutz Cardiac fibrosis occurs early and involves endothelin and at-1 receptors in hypertension due to endogenous angiotensin II J Am Coll Cardiol 41 2003 666 673 (Pubitemid 36223335)
21. A. Burke, A. Farb, Y.-h. Liang, J. Smialek, and R. Virmani Effect of hypertension and cardiac hypertrophy on coronary artery morphology in sudden cardiac death Circulation 94 1996 3138 3145 (Pubitemid 26427479)